PUBLICATION PRINTED MATTER WITH

Brand Owner (click to sort) Address Description
AERIAL Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
AGOTINA-ASTHMA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;The mark consists of the stylized wording AGOTINA-ASTHMA with a design of a series of swooping lines above invoking wind currents.;Color is not claimed as a feature of the mark.;Medical and scientific research in the field of respiratory system; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
AIRWISE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;AIR WISE;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
AKEVETO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
AMONTA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
BELVATO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;The mark consists of the word BELVATO with the design of an arrow extending from below and through the tip of the letter O.;Color is not claimed as a feature of the mark.;
BELVATO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CADENTINA-ASTHMA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;The mark consists of the stylized wording CADENTINA-ASTHMA with swooping lines above CADENTINA invoking wind currents.;CADEN TIN A-ASTHMA;Color is not claimed as a feature of the mark.;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CADENTINA-ASTHMA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CANOTINA-ASTHMA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;The mark consists of the stylized wording CANOTINA - ASTHMA with a series of swooping lines above CANOTINA invoking wind currents.;Color is not claimed as a feature of the mark.;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CARMELINA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
CASIMIR Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CHEVALIER Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CONFIKORE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
CONQUER LES MILLS INTERNATIONAL LIMITED 22 Centre Street 22 Centre Street Auckland 1010 New Zealand Publication of printed matter with respect to fitness and health club related programs and training materials; Publication of electronic media, namely, publication of music and video and audio visual resources with respect to fitness and health club related programs and training materials in digital format; Publication of on-line music and video and audio visual resources with respect to fitness and health club related programs; Publishing online electronic publications, namely, books, booklets, newsletters, magazines, manuals, posters and postcards all in relation to fitness and health club related programs in the field of fitness health and sport, over the Internet;Digital music downloadable from the Internet;
CREDEMY Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
ELDERLINA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
ELDERLINA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;ELDER LINA;Medical and scientific research in the field of diabetes, providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
ELLACTO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
ELUXA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;The wording ELUXA has no meaning in a foreign language.;Medical and scientific research in the field of oncology and respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPA-REG BASAL Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations, including in electronic form;BASAL;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG BP Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
EMPA-REG COMBO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;COMBO;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG DOSE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
EMPA-REG EXTEND Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
EMPA-REG H2H-SITA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;conducting of clinical studies for pharmaceutical preparations;
EMPA-REG H2H-SU Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;H2H-SU;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG MET Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;MET;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG METSU Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations, including in electronic form;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG MIDI Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations, including in electronic form;MDI;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG MONO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
EMPA-REG OUTCOME Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations, including in electronic form;OUTCOME;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG OUTCOME Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies concerning pharmaceutical preparations;The mark consists of the wording EMPA-REG in capitalized gray letters slightly larger and above the word OUTCOME also in gray capital letters. To the left of the wording is an abstract design comprised of several circles of various sizes forming a ring with an irregular circumference, with the circles in the colors red, blue, gray and violet.;The color(s) red (pms 1925), blue (pms 279), grey (pms 424), and violet (pms 527) is/are claimed as a feature of the mark.;OUTCOME;Medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPA-REG PIO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations, including in electronic form;PIO;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG PPG Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;PPG;Conducting of clinical studies for pharmaceutical preparations;
EMPA-REG RENAL Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;RENAL;Conducting of clinical studies for pharmaceutical preparations;
EMPERIAL-PRESERVED Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPERIAL-REDUCED Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPEROR HEART FAILURE STUDIES Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany publication of printed matter with the results of clinical studies involving pharmaceutical preparations, including printed matter in electronic form;The mark consists of the wording Emperor in gray with a stylized O that includes a transparent heart in the middle, a red and blue line extend from the top of the letter o like antennas and each contain a circle near the end of the line; the purple wording Heart Failure Studies is beneath the wording Emperor. There is no claim to background color.;The color(s) gray, red, blue, and purple is/are claimed as a feature of the mark.;HEART FAILURE STUDIES;Medical and scientific research in the fields of cardiovascular and metabolic diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPEROR-PRESERVED Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of diabetes and cardiovascular diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPEROR-REDUCED Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of diabetes and cardiovascular diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPORER-HFPEF Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EMPORER-HFREF Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
EVELUT Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
FINES BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Binger Straße 173 Ingelheim 55218 Germany Publication of printed matter with the results of clinical studies, namely studies with topical anti-rheumatics and analgetics in the treatment of rheumatic diseases and stimulating skin circulation involving musculoskeletal disorders (including in electronic form);Conducting of clinical studies with topical anti-rheumatics and analgetics in the treatment of rheumatic diseases and stimulating skin circulation involving musculoskeletal disorders;
FOOTPRINTS Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
INCOMB Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;IN COMB;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceutical and clinical trials;
ININSI Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
INMARK Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;IN MARK;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceutical and clinical trials;
INSTAGE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;IN STAGE;Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
INTREAD Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;IN TREAD;Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
INTRIP Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;IN TRIP;Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
INVICTAN Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;
LECTRONA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
MARLINA-T2D Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations (including in electronic form);MARLINA-T TWO D;Conducting of clinical studies for pharmaceutical preparations;
MARLINA-T2D Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;MARLINA- T TWO D;T2D;Medical and scientific research in the field of diabetes; providing medical and sioentific research information in the field of pharmaceuticals and clinical trials;
NINOTINA-ASTHMA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;The mark consists of the stylized wording NINOTINA-ASTHMA with a series of swooping lines above NINOTINA-ASTHMA invoking wind currents.;NINO TINA-ASTHMA;Color is not claimed as a feature of the mark.;Medical and scientific research in the field of respiratory diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
OTEMTO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;The mark consists of the word OTEMTO with the design of an arrow extending from below and through the tip of the last letter O;Color is not claimed as a feature of the mark.;
RANIRET Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of ophthalmology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
RE-COVERY DVT/PE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;DVT/PE;[ Medical and scientific research in the field of cardiovascular diseases and disorders; ] providing medical and scientific research information in the field of pharmaceutical and clinical trials;
RE-DUAL PCI Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;PCI;Conducting of clinical studies for pharmaceutical preparations;
RE-SONANCE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations; all of the foregoing relating to pharmaceutical preparations containing dabigatran;
RE-SPECT ESUS Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations including in electronic form;ESUS;Conducting of clinical studies for pharmaceutical preparations;
RE-VECTO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of hemostasis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
RE-VERSE-AD Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of haemostasis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
RESINTA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations; publishing of electronic publications with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research, namely, conducting of clinical trials for pharmaceutical preparations;
REVHEP Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations; publishing of electronic publications with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research, namely, conducting of clinical trials for pharmaceutical preparations;
SILBERLINA Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;The wording SILBERLINA has no meaning in a foreign language.;Medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
STARTVERSO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations; publishing of electronic publications with the results of clinical studies involving pharmaceutical preparations;The mark consists of the stylized text STARTVERSO below an arc of straight lines with varying shading.;START VERSO;Color is not claimed as a feature of the mark.;Medical and scientific research, namely, conducting of clinical trials for pharmaceutical preparations;
TIVACITO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations;The wording TIVACITO has no meaning in a foreign language.;
TRIVINCI Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceutical and clinical trials;
TRONARTO Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations (including in electronic form);Conducting of clinical studies for pharmaceutical preparations;
VANGOH Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceutical and clinical trials;
VOLTAIRE Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the field of immunology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
VONGUARD Boehringer Ingelheim International GmbH Binger Strasse 173 Ingelheim 55216 Germany Publication of printed matter with the results of clinical studies involving pharmaceutical preparations;Medical and scientific research in the fields of respiratory diseases; providing medical and scientific research information in the field of pharmaceutical and clinical trials;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Even if printing is carried out on an unprinted surface of a print sheet containing confidential information, the confidential information is prevented from leaking out, thereby increasing reuse rate. To achieve this, both print data instructed by a host apparatus and an already printed print sheet have a security level of print contents and manager information on the print matter as print matter attributes. Then, when the print data is printed on an unprinted surface, it is determined whether the print data can be printed on a fed print sheet, from the print matter attributes of the print data and of the print sheet. Further, print sheets are prepared beforehand every print matter attributes and a print sheet to be fed is selected on the basis of the print matter attributes of the print data.